Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

After A Record Year, China Healthcare IPOs Have Endured A Tough 2011

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Last year was a banner year for China's life sciences companies, with 34 new stock offerings globally that raised $6.9 billion from the capital market. But the first half of 2011 has been a disappointment across healthcare sectors for Chinese firms
Advertisement

Related Content

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2011
From Biosimilars To Corporate Venture: China's Top Biotech Takes Another Step
From Biosimilars To Corporate Venture: China's Top Biotech Takes Another Step
China Pharma And Distributors Suffer From Essential Drug System And Price Cuts
China Pharma And Distributors Suffer From Essential Drug List System And Price Cuts
Creative Funding Options For China; Investors Battle Perception of Home Court Advantage
With Pfizer As Cornerstone Investor, Will Shanghai Pharmaceutical Be Largest Pharma IPO Ever?
China NT Pharma's Hong Kong IPO Could Trigger Consolidation In Distribution Sector
China NT Pharma's Hong Kong IPO Could Trigger Consolidation In Distribution Sector
At PharmAsia Summit, VCs Discuss Financing Innovation in Asia
Advertisement
UsernamePublicRestriction

Register

SC078644

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel